Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

Presentations Access:

clear all | select all

Presentation Access:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 224
Educational Session: "Omics" Technologies: Overcoming Challenges to Implementation
Overview
Dr. Graham A. Colditz
Harvard Medical School, Boston, MA
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 2:00 PM-3:30 PM
Educational Session: "Omics" Technologies: Overcoming Challenges to Implementation
Integrative Epidemiology
Dr. Gordon B. Mills
UT M.D. Anderson Cancer Ctr., Houston, TX
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 2:00 PM-3:30 PM
Educational Session: "Omics" Technologies: Overcoming Challenges to Implementation
Improving the Reliability and Efficiency of Proteomics and Genomics Research About Diagnosis and Prognosis
Dr. David F. Ransohoff
University of North Carolina, Chapel Hill, NC
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 2:00 PM-3:30 PM
Educational Session: "Omics" Technologies: Overcoming Challenges to Implementation
Validation of the 21 Gene Oncotype DX Breast Cancer Assay: Clinical Trial Cohorts and Population-Based Studies
Dr. Steven Shak
Genomic Health, Redwood City, CA
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 2:00 PM-3:30 PM
Distinguished Lecture on Targets for Cancer Prevention
Can the Switch to the Angiogenic Phenotype be Prevented?
Dr. Judah Folkman
Harvard Medical School, Boston, MA
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 4:00 PM-6:45 PM
Keynote Address
Future Worldwide Health Effects of Current Smoking Patterns: The Hazards of Smoking and the Benefits of Stopping
Sir Richard Peto
University of Oxford, Oxford, England
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 4:00 PM-6:45 PM
Opening Keynote Session
Welcome and Remarks
Margaret Foti, Ph.D., M.D. (h.c.)
CEO, American Association for Cancer Research
Scott M. Lippman, M.D.
UT M.D. Anderson Cancer Ctr., Houston, TX
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 4:00 PM-6:45 PM
Opening Keynote Session
Cancer Control Strategies Worldwide
Dr. Prabhat Jha
University of Toronto, Toronto, ON, Canada
from 2006 Frontiers in Cancer Prevention Research conference on November 12, 2006 4:00 PM-6:45 PM
Plenary Session: Tissue Injury, Tissue Repair, and Prevention of Carcinogenesis
Integrating Inflammation
Dr. Carl F. Nathan
Cornell Medical College, New York, NY
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 8:00 AM-10:00 AM
Plenary Session: Tissue Injury, Tissue Repair, and Prevention of Carcinogenesis
Oxidative Damage to DNA and Proteins
Dr. Lawrence J. Marnett
Vanderbilt University, Nashville, TN
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 8:00 AM-10:00 AM
Plenary Session: Tissue Injury, Tissue Repair, and Prevention of Carcinogenesis
Inflammatory Angiogenesis: A Target for Chemoprevention
Dr. Adriana Albini
IRCCS Multimedica, Milan, Italy
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 8:00 AM-10:00 AM
Plenary Session: Nutrition, Activity, Obesity, and Cancer
Physical Activity and Cancer: Progress and "Opportunities"
Dr. Leslie Bernstein
USC/Norris Comprehensive Cancer Center, Los Angeles, CA
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 2:00 PM-4:00 PM
Plenary Session: Nutrition, Activity, Obesity, and Cancer
Diet and Cancer: The Fourth Paradigm
Dr. Walter C. Willett
Harvard School of Public Health, Boston, MA
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 2:00 PM-4:00 PM
Plenary Session: Nutrition, Activity, Obesity, and Cancer
Community Approaches to Obesity Treatment and Prevention
Dr. Robert W. Jeffery
University of Minnesota, Minneapolis, MN
from 2006 Frontiers in Cancer Prevention Research conference on November 13, 2006 2:00 PM-4:00 PM
Plenary Session: Targeting Stem/Progenitor Phenotypes for Cancer Prevention
Implications of the Cancer Stem Cell Hypothesis for Early Detection and Prevention
Dr. Max S. Wicha
University of Michigan, Ann Arbor, MI
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 8:00 AM-10:00 AM
Plenary Session: Challenges to Chemoprevention Agent Development in the New Era of Molecular Targeting
Overview
Dr. Richard Schilsky
Univ. of Chicago, Chicago, IL
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 1:00 PM-3:00 PM
Plenary Session: Challenges to Chemoprevention Agent Development in the New Era of Molecular Targeting
Preclinical Chemopreventive Agent Development
Dr. James A. Crowell
National Cancer Institute, Bethesda, MD
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 1:00 PM-3:00 PM
Plenary Session: Challenges to Chemoprevention Agent Development in the New Era of Molecular Targeting
Challenges to Drug Development in the Era of Molecular Targeting: Clinical Chemoprevention Trials
Dr. Eva Szabo
National Cancer Institute, Bethesda, MD
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 1:00 PM-3:00 PM
Plenary Session: Challenges to Chemoprevention Agent Development in the New Era of Molecular Targeting
Regulatory Challenges for Prevention Agent Development
Dr. Ann T. Farrell
Food and Drug Administration, Silver Springs, MD
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 1:00 PM-3:00 PM
Plenary Session: Challenges to Chemoprevention Agent Development in the New Era of Molecular Targeting
Challenges to the Pharmaceutical Industry
Dr. Neil W. Gibson
OSI Pharmaceuticals, Inc., Farmingdale, NY
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 1:00 PM-3:00 PM
AACR-Cancer Research and Prevention Foundation Award Lecture
A Tobacco-Specific Lung Carcinogen: from Basic Research to Tobacco Control
Dr. Stephen S. Hecht
University of Minnesota Cancer Center, Minneapolis, MN
from 2006 Frontiers in Cancer Prevention Research conference on November 14, 2006 5:00 PM-6:00 PM
Plenary Session: Mechanisms of Chemoprevention with Foods
One-Carbon Nutrients and Colon Cancer: Mechanisms
Dr. Joel B. Mason
Tufts University, Boston, MA
from 2006 Frontiers in Cancer Prevention Research conference on November 15, 2006 8:00 AM-10:00 AM
Plenary Session: Mechanisms of Chemoprevention with Foods
Novel Tomato Products for Cancer Prevention
Dr. Steve K. Clinton
The Ohio State University, Columbus, OH
from 2006 Frontiers in Cancer Prevention Research conference on November 15, 2006 8:00 AM-10:00 AM
Plenary Session: Mechanisms of Chemoprevention with Foods
Novel Approaches for Chemoprevention of Colon Cancer by Food Components
Dr. Bandaru S. Reddy
Rutgers: The State University of New Jersey, Piscataway, NJ
from 2006 Frontiers in Cancer Prevention Research conference on November 15, 2006 8:00 AM-10:00 AM
Concurrent Session: Epigenomics and Imprinting
Overview
Dr. Randy L. Jirtle
Duke Univ. Medical Ctr., Durham, NC
from 2006 Frontiers in Cancer Prevention Research conference on November 15, 2006 10:15 AM-12:15 PM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 224